• Sun. May 19th, 2024

Whereas 27HC may have several functions within cells its role as an LXR agonist which inhibits cholesterol production and increases cholesterol efflux from cells is very well established


Dec 4, 2021

Whereas 27HC may have several functions within cells its role as an LXR agonist which inhibits cholesterol production and increases cholesterol efflux from cells is very well established. exhibited in appropriate animal models that this impact of high fat diet on tumor pathogenesis can be mitigated by statins or by small molecule inhibitors of CYP27A1. These findings suggest that pharmacological or dietary modifications that lower total cholesterol, and by inference 27HC, are likely to reduce the impact of obesity/metabolic syndrome on breast cancer incidence. gene in mice creating a model in which dietary fat results in a dramatic increase in LDL-cholesterol. In APOE?/? mice the effects of a Western diet on tumor growth and metastasis are greatly accentuated suggesting that cholesterol is usually pathogenic in breast cancer. However, you will find two significant caveats to this conclusion. The first is that in most of the key studies performed in this model utilize diets high in both excess fat and cholesterol and thus the specific contributions of dietary cholesterol, endogenously produced cholesterol, and dietary fat could not be determined (18). A more significant issue is the fact that this APOE?/? mice display a very substantial generalized inflammatory response and this could, impartial of cholesterol status, impact tumor pathogenesis. To circumvent these issues we evaluated the specific effects of hypercholesterolemia on tumor growth and metastasis in the MMTV-PyMT mouse model of mammary malignancy (29). It was noted in this study that increased dietary intake of cholesterol alone resulted in a significantly decreased tumor latency and increased tumor growth, supporting the idea that cholesterol itself can impact tumor pathophysiology (Physique 1). Open in a separate window Physique 1 Cholesterol stimulates tumor growth in a mouse model of ER-positive breast cancerThe impact of hypercholesterolemia on breast malignancy pathogenesis was evaluated in mice genetically designed to express the Lansoprazole sodium PyMT oncogene in the mammary gland. In this well-validated model of ER-positive breast cancer tumors arise spontaneously. For this study mice were placed on either a control diet or a high cholesterol diet (2% cholesterol), ad libitum from weaning. At-5 weeks of age mice were ovariectomized and monitored for the appearance of the first palpable tumors, the growth of which was then recorded through time. (Figure adapted from 342: 1094-1098, 2013) Realizing the problems with the APOE?/? mouse model we required advantage of a related model in which the mouse locus is usually replaced with the human APOE allele (30). CXCL5 In this model dietary fat results in increased serum cholesterol absent a generalized inflammatory response. As expected the growth of breast Lansoprazole sodium tumors propagated in this model were significantly increased Lansoprazole sodium when the mice were fed a high excess fat diet and importantly this effect could be attenuated by administering a statin (29). When taken together it appears as if cholesterol is usually a pathogenic agent in breast cancer and that the impact of HFD on breast cancer risk can be attributed to increased serum cholesterol. Mechanisms underlying the pathological actions of cholesterol in breast malignancy The intracellular level of free cholesterol within most cells is usually kept relatively constant by a series of tightly regulated homeostatic processes. Excess free cholesterol can be accommodated by its partitioning into membranes and/or its esterification and subsequent storage in lipid droplets. Whereas these latter processes enable a somewhat passive regulation of intracellular levels of cholesterol, it is alterations in the processes that control the efflux, influx, and synthesis of this lipid that have the most.